🔎 Trials Near Me

Akèy › Krèz › Washington

Etid klinik pou Krèz nan Washington, DC

13 etid pou Krèz ap chèche patisipan nan sit nan ak bò kote Washington (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Investigating Epilepsy: Screening and Evaluation

Ap rekriteEtid obsèvasyon
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 8 a 110 · Tout sèks · Mizajou Oct 2, 2026 · NCT03478852

Natural History of Treated Neurocysticercosis and Long-Term Outcomes

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 3 a 99 · Tout sèks · Mizajou Oct 2, 2026 · NCT00001205

Tumor Related Epilepsy

Ap rekriteEtid obsèvasyon
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 8 a 99 · Tout sèks · Mizajou Oct 2, 2026 · NCT02639325

A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures

Ap rekriteFaz 1
  • Mid-Atlantic Epilepsy and Sleep Center, Bethesda · 7 mi lwen
Laj 12 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT07233239

Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1

Ap rekriteFaz 3
  • Mid-Atlantic Epilepsy and Sleep Center, Bethesda · 7 mi lwen
Laj 18 a 75 · Tout sèks · Mizajou Oct 1, 2026 · NCT07563881

RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures

Ap rekriteFaz 2
  • Mid Atlantic Epilepsy and Sleep Center, Bethesda · 7 mi lwen
Laj 18 a 70 · Tout sèks · Mizajou Oct 1, 2026 · NCT06798896

Investigation of Blood-Brain-Barrier Breakdown Using Manganese Magnetic Resonance Imaging in Drug-Resistant Epilepsy

Ap rekriteFaz 1
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 18 a 60 · Tout sèks · Mizajou Sep 28, 2026 · NCT02531880

Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))

Ap rekriteFaz 3
  • George Washington University, Washington D.C.
Laj 18 a 75 · Tout sèks · Mizajou Jun 9, 2026 · NCT05135091

A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)

Ap rekriteFaz 3
  • Mid-Atlantic Epilepsy and Sleep Center, Bethesda · 7 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou May 14, 2026 · NCT05716100

Pediatric Dose Optimization for Seizures in Emergency Medical Services

Ap rekriteFaz 3
  • Children's National Hospital, Washington D.C.
6 Months – 13 Years · Tout sèks · Mizajou Sep 30, 2025 · NCT05121324

Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults

Ap rekriteFaz 3
  • Mid-Atlantic Epilepsy and Sleep Center, Bethesda · 7 mi lwen
Laj 4 a 55 · Tout sèks · Mizajou Jul 24, 2025 · NCT05219617

An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic Seizures

Ap rekriteFaz 2
  • Praxis Research Site, Bethesda · 7 mi lwen
Laj 18 a 75 · Tout sèks · Mizajou Apr 3, 2025 · NCT06908356

Epilepsy Learning Healthcare System (ELHS)

Ap rekriteEtid obsèvasyon
  • Epilepsy Foundation, Bowie · 17 mi lwen
Tout laj · Tout sèks · Mizajou Aug 30, 2024 · NCT06265103

Etid Krèz nan lòt vil

Lòt etid nan Washington

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.